Cryosectioning of Synthetic Biocompatible Implants Using UV-Curable Resin for Enhanced Immunofluorescence Analysis

Summary

This work presents a cryosectioning protocol that uses UV-curable resin stabilization to maintain the integrity of the implant-tissue interface while preserving antigen accessibility, enabling reliable, high-resolution immunofluorescence analysis of synthetic polymer implants.

Abstract

Histological evaluation of synthetic, biocompatible implants poses significant technical challenges due to the incompatibility between conventional tissue processing methods and the physicochemical properties of these materials. Current approaches utilizing complete resin embedding provide adequate structural preservation but severely compromise epitope accessibility, thereby limiting immunohistochemical applications essential for characterizing host immune responses. Conversely, conventional paraffin embedding exhibits poor adhesion to synthetic substrates and limits antibody selection for comprehensive immunological profiling. Standard cryosectioning protocols enhance immunohistochemical compatibility by improving antigen preservation; however, these methods often result in inadequate structural integrity of implant-containing specimens, compromising morphological assessment and sectioning quality. To address these limitations, a novel processing protocol was developed that incorporates a UV-curable resin for selective stabilization of implant-tissue constructs prior to cryosectioning. This methodology employs a photopolymerizable resin to provide mechanical support while preserving epitope accessibility and antigenic determinants, which are typically compromised by full resin polymerization. The protocol enables reproducible generation of high-quality sections at optimal thickness for immunofluorescence evaluation, achieving superior structural preservation compared to standard frozen sectioning without the extensive crosslinking that limits antibody penetration in conventional resin-embedded specimens. This approach represents a practical, cost-effective solution for histological processing of synthetic implants, offering enhanced analytical capabilities for biocompatibility assessment and facilitating detailed characterization of local immune responses at implant-tissue interfaces.

Introduction

Immunofluorescence microscopy is an essential analytical technique in regenerative medicine research, facilitating visualization of tissue architecture and cellular composition using fluorophore-conjugated antibodies. This methodology integrates the molecular specificity of immunochemical recognition with the sensitivity and versatility of fluorescence detection, enabling detailed observation of cellular target distributions within their tissue microenvironments. Immunofluorescence approaches encompass both direct and indirect labeling strategies, with indirect immunofluorescence protocols providing enhanced signal amplification through secondary antibody systems conjugated to diverse fluorophores spanning the visible and near-infrared spectrum¹. The methodology's inherent ability for simultaneous multi-target detection through spectral separation facilitates comprehensive phenotypic characterization of heterogeneous cellular populations and their spatial relationships within complex tissue microenvironments².

The technical capabilities of immunofluorescence microscopy extend beyond conventional protein localization to encompass quantitative analytical applications, including fluorescence intensity measurements, colocalization analyses, and spatial distribution assessments critical for understanding cellular function and tissue organization³. In the context of implant biocompatibility research, immunofluorescence analysis provides critical insights into host immune responses, including foreign body reactions, inflammatory cascades, and tissue integration processes that determine implant acceptance or rejection at the cellular and molecular levels⁴.

The successful implementation of immunofluorescence protocols requires careful consideration of tissue processing methodologies that preserve morphological integrity while maintaining fluorescent signal and minimizing background autofluorescence. Traditional embedding media selection depends on tissue type, downstream analytical requirements, and the specific antigens of interest. For synthetic materials and implants, current literature primarily recommends complete resin embedding to maintain structural stability during sectioning procedures⁵. However, this approach presents significant limitations due to the requirement for specialized ultramicrotomes and blades for sectioning polymerized resin blocks, representing substantial equipment investment and technical expertise. Paraffin embedding, while providing adequate structural support for sectioning, introduces conformational changes to antigenic determinants during fixation and processing through extensive dehydration, chemical hardening, and infiltration with organic solvents that can denature proteins and mask epitopes. Paraffin processing also produces intrinsic autofluorescence interference that compromises signal detection and quantitative analysis. These alterations necessitate antigen retrieval procedures, typically involving heat-induced epitope retrieval (HIER) or proteolytic-induced epitope retrieval (PIER), to restore antibody accessibility⁶. Despite these interventions, numerous commercially available antibodies remain incompatible with paraffin-embedded specimens, and the harsh retrieval conditions can further compromise fluorescent signal quality and introduce photobleaching artifacts.

Cryosectioning offers an alternative processing methodology for immunofluorescence applications. Two cryopreservation methods can be used for tissue preparation. The first approach involves rapid cryopreservation by direct immersion of fresh tissue specimens in an isopentane bath pre-cooled with liquid nitrogen to achieve temperatures below –20 °C, followed by sectioning using cryostat microtomes equipped with temperature-controlled cutting chambers. The second protocol uses a short fixation period in paraformaldehyde (PFA) or formalin, followed by cryoprotection via graded sucrose infiltration before freezing. The cryopreservation process creates a rigid matrix that maintains tissue integrity while preserving native protein conformations essential for antibody recognition. Frozen sectioning maintains tissues in a near-native state with minimal chemical modifications⁷, thereby reducing the need for harsh antigen retrieval procedures and enabling the use of a broader range of primary antibodies, including those incompatible with paraffin-embedded tissues due to epitope masking or denaturation⁸.

The cryosectioning process typically utilizes optimal cutting temperature (OCT) compound, a water-soluble embedding medium composed of polyvinyl alcohol and polyethylene glycol that provides structural support during sectioning while remaining transparent and compatible with fluorescence detection systems. OCT embedding facilitates the generation of thin, uniform sections ranging from 5–15 µm in thickness, depending on the specific analytical requirements and tissue characteristics⁹. The preservation of native protein conformations in frozen sections maintains optimal signal-to-noise ratios essential for quantitative immunofluorescence analysis, while also retaining intact epitopes that allow the use of a broader range of primary antibodies, including those incompatible with paraffin-embedded tissues⁸.

However, frozen tissue sectioning presents unique technical challenges, particularly when processing synthetic implant materials that possess distinct physicochemical properties compared to native biological tissues. The differential thermal expansion between synthetic polymers and biological tissue interfaces during freezing can result in localized mechanical stress that compromises structural integrity and creates sectioning artifacts¹⁰. Furthermore, the inherent rigidity of many synthetic materials relative to frozen biological tissues can cause blade deflection during sectioning, resulting in uneven section thickness and damage to both the specimen and cutting equipment. These technical limitations necessitate specialized processing protocols that can accommodate the unique requirements of implant-containing specimens while maintaining the advantages of frozen sectioning for immunofluorescence applications.

To address these limitations, this study developed a cryosectioning protocol that combines selective UV-curable resin stabilization with controlled cryostat sectioning parameters to enable high-resolution, multi-parameter immunofluorescence analysis of implant-tissue constructs.

Protocol

This research was performed in compliance with Mayo Clinic Institutional Animal Care and Use Committee (IACUC) guidelines under approval number A00003765-18-24. All procedures involving synthetic biocompatible implants were conducted under sterile conditions, in accordance with appropriate biosafety protocols.

1. Specimen processing and cryoprotection

NOTE: Handle formalin exclusively in a chemical fume hood and wear appropriate personal protective equipment (PPE), because formalin contains formaldehyde, a potent irritant, sensitizer, and carcinogen.

1. Fix tissue-integrated biocompatible synthetic implant specimens in 10% neutral buffered formalin overnight at 4° C using a minimum of 10 volumes of fixative relative to tissue volume to ensure complete immersion and adequate penetration. The objective of this limited fixation period is to achieve minimal cross-linking while preserving tissue morphology. (See Table of Materials for materials used in Protocol.)
2. Transfer specimens to 15% sucrose solution prepared in phosphate-buffered saline (PBS) for overnight incubation at 4° C with gentle agitation. Ensure complete sucrose infiltration as evidenced by tissue sinking.
3. Transfer specimens to 30% sucrose solution in PBS for a second overnight incubation at 4° C. Confirm complete equilibration by tissue sinking to the container bottom, indicating adequate sucrose infiltration and water displacement.
4. Prepare a 1:1 volumetric ratio of 30% sucrose solution and OCT compound. Incubate specimens in this transitional medium for 2 h at 4° C, then transfer to 100% OCT for 1 h to achieve complete equilibration, as indicated by a uniformly opaque appearance of the tissue.
5. Position specimens carefully in standard cryomolds filled with fresh OCT compound, ensuring optimal orientation for sectioning planes. Orient with the implant-tissue interface accessible for subsequent procedures. Eliminate air bubbles using pre-cooled forceps.
6. Place filled cryomolds immediately on the dry ice platform to create a temperature gradient promoting rapid ice crystal formation from bottom upward. Monitor for 10–15 min until complete solidification, confirmed by the characteristic opaque white appearance of frozen OCT compound. Transfer frozen blocks to –80° C storage or directly to the cryostat chamber for immediate sectioning.

2. Cryostat setup and initial sectioning

1. Maintain the cryostat temperature-controlled chamber at –15° C. Verify temperature using integrated digital monitoring and equilibrate overnight prior to specimen introduction.
2. Install new disposable blades. Set the blade angle for combined synthetic-biological material sectioning according to the manufacturer's specifications.
3. The desired section thickness (50–100 µm) is programmed into the cryostat by selecting the Thickness setting on the control panel, adjusting using the arrow keys, and confirming the parameter by pressing the Set key.
4. Advance through the embedded specimen to reach the predetermined depth corresponding to the implant-tissue interface. Monitor advancing section surface to identify optimal plane for UV-resin application, characterized by subtle changes in tissue opacity and initial implant-periphery exposure, and depth is confirmed when these features remain consistently visible across successive trimmed sections.
   NOTE: Halt sectioning immediately upon reaching the critical interface to prevent advancement beyond the target region.

3. UV-Curable resin application

NOTE: Handle UV‑curable resin in a well-ventilated area while wearing appropriate PPE and protect eyes and skin from LED‑UV curing light. These resins contain irritants that can cause skin and eye reactions, and LED‑UV exposure can result in UV-induced eye injury.

1. Cut parafilm using scissors to dimensions 2–3 mm exceeding the implant perimeter. Carefully separate from the protective paper backing using sterile forceps.
2. Dispense 5–10 µL UV-curable resin onto exposed parafilm surface (Figure 1A). Resin volume is optimized by conducting preliminary test applications in which incremental volumes are dispensed, and the resulting spread is visually evaluated to ensure uniform coverage of the specimen surface without overflow or excessive resin accumulation that would interfere with sectioning.
3. Replace protective paper backing immediately over resin-loaded parafilm. Apply a polyurethane seam roller (2 inches) with consistent pressure in overlapping, parallel passes, followed by perpendicular passes to achieve a thin, uniform resin layer (Figure 1B).
4. Remove protective paper layer carefully, revealing uniformly distributed resin film. Position resin-parafilm directly over the exposed implant surface, ensuring precise alignment with the implant-tissue interface (Figure 1C).
5. Apply polyurethane seam roller from implant center outward to eliminate air bubbles and ensure intimate contact between resin and both synthetic and biological surfaces (Figure 1D).
6. Position 405 nm wavelength UV LED light source at 2–3 cm distance directly at the implant surface. Expose for 90 s to ensure complete polymerization, verified by tactile assessment of resin hardness and non-tacky characteristics (Figure 1E). Place UV-protective cover over cryostat chamber window prior to UV photopolymerization to shield operator from harmful UV exposure during resin curing procedure.

4. Section recovery and slide preparation

1. Remove parafilm using a single continuous motion to prevent mechanical disruption of the resin-tissue interface. Complete resin adherence is confirmed by inspecting the exposed surface under cryostat lighting for uniform resin coverage, absence of lifting at the tissue edge, and lack of visible parafilm residue.
2. Section specimens to a predetermined 8 µm thickness using a calibrated microtome advance mechanism. Monitor each section for consistent thickness and absence of artifacts (compression, tearing, incomplete sectioning). Position the anti-roll plate optimally to prevent curling (Figure 1F).
   NOTE: Hydrophilic, positively charged adhesive glass slides are used because they provide superior retention of challenging specimens, improving adherence during section transfer and subsequent processing. Label slides individually prior to section transfer.
3. Position slide adhesive surface, ensuring initial contact at section edge before progressive contact across entire area. Ensure the UV-cured resin surface adheres to the slide while maintaining the tissue surface upward for immunofluorescence (Figure 1G).
4. Press the section-slide assembly gently to eliminate air bubbles. Verify proper orientation under cryostat lighting, confirming the intact implant-tissue interface.

5. Storage and preservation

1. Place completed slides in pre-labeled storage boxes at –20° C for applications requiring processing within 72 h.
2. Utilize – 80° C conditions for preservation periods exceeding one week.

6. Immunofluorescence staining protocol

NOTE: Handle pepsin with appropriate PPE, as it is a skin and respiratory irritant.

1. Retrieve slides from storage and transfer to humidity chambers for 15–20 min for room temperature equilibration.
2. Perform three sequential 2-minute PBS washing cycles.
3. Antigen retrieval:
   1. Heat-induced epitope retrieval (HIER) method: Position slides horizontally in microwave-safe containers with 1x target retrieval solution. Microwave (1000-watt output) at high power, for 15 min, followed by cooling to room temperature.
   2. Proteolytic-induced epitope retrieval (PIER) method: Apply 100–150 µL ready-to-use pepsin solution per section. Cover with temporary plastic coverslips and incubate at 37° C for 10 min in a humidified chamber.
4. Perform three sequential PBS washing cycles (2 min each).
5. Apply 1 mL blocking solution containing 0.1% saponin and 2.5% normal goat serum in PBS. Incubate 30 min at room temperature in a humidified chamber.
6. Perform three sequential PBS washing cycles (2 min each).
7. Apply 100 µL primary antibody solutions at optimized concentrations:
   1. Anti-Collagen IV rabbit polyclonal at 1:100 dilution.
   2. Anti-Laminin rabbit polyclonal at 1:500 dilution.
   3. Anti-F4/80 rabbit monoclonal antibody at 1:500 dilution.
8. Cover with temporary plastic coverslips and incubate overnight at 4° C in humidified chambers.
9. Perform three PBS washing cycles (2 min each).
10. Apply secondary antibodies at a 10 µg/mL concentration.
    1. Donkey Anti-Rabbit IgG Alexa Fluor Plus 555
    2. Goat Anti-Rabbit IgG Alexa Fluor 488
11. Incubate 60 min at room temperature in darkened conditions.
12. Optional wheat germ agglutinin (WGA) staining:
    1. Apply WGA-Alexa Fluor 647 at 5 µg/mL in PBS with 2.5% normal goat serum.
    2. Cover and incubate at 37° C for 30 min. Perform three sequential 2 min PBS washing cycles.
13. Apply 80 µL hard-setting mounting media with nuclear counterstain per section.
14. Cover the coverslip with the cover glass to eliminate air bubbles.
15. Allow slides to cure horizontally at room temperature for 2 h in darkness.
16. Store at 4° C for up to one week for optimal imaging quality.

7. Fluorescence microscopy and image acquisition

1. Perform imaging using an inverted fluorescence microscope with manufacturer filter sets: 360/460 nm excitation/emission, 470/525 nm excitation/emission, 545/605 nm excitation/emission, 620/700 nm excitation/emission.
2. Images are captured by selecting each fluorescence channel within the Filter menu of the microscope software. Prior to exposure optimization, a black balance procedure is performed by selecting Adjust Black Balance to ensure accurate baseline correction for each channel. Exposure parameters are then optimized by opening the Image Capture window, enabling Live mode, and adjusting the Exposure and Light Intensity controls until a high signal‑to‑noise ratio is achieved without pixel saturation. Saturation is monitored using the software’s Histogram display and the Highlight Saturated Pixels tool. Each channel is adjusted independently prior to image acquisition.
3. Perform automated tile acquisition with the manufacturer’s 10% overlap between adjacent fields. Maintain automated focus adjustment throughout the acquisition sequence.

Results

Section quality assessment and optimization
Following UV-resin stabilization and sectioning at 8 µm thickness, collect sections onto adhesive slides and evaluate for quality control. High-quality sections demonstrate intact morphology without significant cracks or fracturing artifacts, with continuous tissue architecture and a preserved implant-tissue interface (Figure 2A). Sections exhibiting substantial structural damage, including fracturing or tissue separation from ...

Discussion

This UV‑curable resin stabilization method provides an alternative approach for cryosectioning OCT‑embedded tissue specimens containing synthetic materials that are otherwise difficult to process using standard frozen sectioning techniques. Although a variety of adhesive options, such as charged slides, tissue‑bonding tapes, and other stick-on supports, are available to help prevent tissue sections or fragile samples from detaching during handling, these products offer slide adhesion and do not supply t...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
5W Gooseneck Ultraviolet Light 395–405 nm for resin curing	Amazon	UPC ‎603335835561
Antibody - Anti-F4/80 (Monoclonal)	Abcam	ab300421	1:500
Antibody - Collagen IV (Polyclonal)	Abcam	ab6586	1:100
Antibody - Donkey Anti-Rabbit IgG AlexaFluor Plus 555	Invitrogen	A32794	10 ug/mL
Antibody - Goat anti-Rabbit IgG AlexaFluor 488	Invitrogen	A-11008	10 ug/mL
Antibody - Laminin (Polyclonal)	Invitrogen	PA1-16730	1:500
BioMed Clear	Formlabs	FLBMCL01	Biocompatible material #1
BioMed Durable	Formlabs	FLBMDU01	Biocompatible material #2
Buffered 10% Formalin	Cardinal Health	C4320-101
BZ-X Filter Cy5	Keyence	OP-87766	Filter Set
BZ-X Filter DAPI	Keyence	OP-87762	Filter Set
BZ-X Filter GFP	Keyence	OP-87763	Filter Set
BZ-X Filter TRITC	Keyence	OP-87764	Filter Set
BZ-X800 Analyzer software	Keyence	BZ-X800	Integrated Software
Fisherbrand Premium Coverglass  50 x 24 mm	Fisher Scientific	12-544-14
Form4B 3D Printer	FormLabs	F4B-Printer
Form4 Resin Tank	Formlabs	RT-F4-01
Goat Serum	Gibco	16210064
HM525 NX Cryostat	Epredia	956641EC
Household Microwave Oven	Panasonic	NN-S766BA	1000 watt output
IHC-Tek Plastic Coverslips 24 mm x 60 mm	IHC World	IW-2601	Temporary coverslip
JDiction Low Viscosity UV Resin	Amazon	6974143904430	High autofluorescence
Keyence BZ-X800	Keyence	BZ-X800
Let's Resin UV Resin Clear Hard Type	Amazon	ALR00038	High autofluorescence
Let's Resin Clear UV Resin High Viscosity Type	Amazon	ALR00048
Matsunami MAS Micro Slide Glass Slides	Newcomer Supply	SUMAS1190	Adhesive Slide
Medpor Surgical Implant	Stryker	8662	Biocompatible material #3
Mr. Resin UV Resin Crystal Clear	Amazon	B08FRF9QTB	High autofluorescence
MX35 Ultra Microtome Blade	Epredia	3053835
Parafilm M Laboratory Film	Parafilm	P7543-1EA
Pepsin	Sigma	R2283-15ML
Phosphate Buffered Saline pH 7.4	Sigma	P3813
Plan Apo λ 40X	Keyence	BZ-PA40	Objective Lens
Plan Apo λ 4X	Keyence	BZ-PA04	Objective Lens
Polyurethane Seam Roller	Amazon	682698799567
ProLong Glass Antifade Mountant with NucBlue Stain	Invitrogen	P36985	Hoechst 33342 Counterstain
Saponin	Millipore	558255-100GM
StainTray	Simport	M920-2
Sterile Silicone Sheeting	Bentec	PR72034-51N
Target Retrieval Solution, Citrate pH6	Agilent	S236984-2
Tissue-Tek O.C.T Compound	Sakura	4583
Wheat Germ Agglutinin AlexaFluor 647	Invitrogen	W32466	5 ug/mL